The People of Tulane Cancer Center Research
Yan Dong, Ph.D.
Y Zhan, G Zhang, X Wang, Y Qi, S Bai, D Li, T Ma, O Sartor, EK Flemington, H Zhang, P Lee, and Y Dong. (2017) Interplay between cytoplasmic and nuclear androgen receptor splice variants mediate castration resistance. Molecular Cancer Research, 15, 59-68. PMID: 27671337. Featured in the "Molecular Cancer Research Highlights: Selected Articles from This Issue" with a figure.
S Cao, Y Zhan, and Y Dong. (2016) Emerging data on androgen receptor splice variants in prostate cancer. Endocrine-Related Cancer, Invited review. 23:T199-T210. PMCID:PMC5107136. Featured in “Uro Today”.
D Xu, Y Zhan, Y Qi, B Cao, S Bai, W Xu, SS Gambhir, P Lee, O Sartor, EK Flemington, H Zhang, CD Hu, and Y Dong. (2015) Androgen receptor splice variants dimerize to transactivate target genes. Cancer Research, 75, 3663-3671. PMCID:PMC4558376. Featured in “MDLinx”, “Just Cancer News”, “BioWorld from Thomson Reuters”. Editorial: Emmanuel S. Antonarakis and Jun Luo. (2015) AR splice variant dimerization - clinical implications Nature Reviews Urology, 12, 431-433.
B Cao, Y Qi, G Zhang, D Xu, Y Zhan, X Alvarez, Z Guo, X Fu, SR Plymate, O Sartor, H Zhang, and Y Dong. (2014) Androgen Receptor Splice Variants Activating the Full-Length Receptor in Mediating Resistance to Androgen-Directed Therapy. Oncotarget, 5, 1646-56. PMCID:PMC4039237.
Y Zhan, B Cao, Y Qi, S Liu, Q Zhang, W Zhou, D Xu, H Lu, O Sartor, W Kong, H Zhang, and Y Dong. (2013) Methylselenol Prodrug Enhances MDV3100 Efficacy for Treatment of Castration-Resistant Prostate Cancer. International Journal of Cancer, 133, 2225-33. PMCID:PMC3750963. Featured in “MDLinx”.
B Cao, X Liu, J Li, S Liu, Y Qi, Z Xiong, A Zhang, T Wiese, X Fu, J Gu, PS Rennie, O Sartor, BR Lee, C Ip, L Zhao, H Zhang, and Y Dong. (2013) 20(S)-Protopanaxadiol-aglycone Downregulation of the Full-length and Splice Variants of Androgen Receptor. International Journal of Cancer, 132, 1277–1287. PMCID:PMC3509250.
1430 Tulane Ave, New Orleans, LA 70112 email@example.com